DE602006004057D1 - Nem ace-hemmer und herstellungsverfahren dafür - Google Patents

Nem ace-hemmer und herstellungsverfahren dafür

Info

Publication number
DE602006004057D1
DE602006004057D1 DE602006004057T DE602006004057T DE602006004057D1 DE 602006004057 D1 DE602006004057 D1 DE 602006004057D1 DE 602006004057 T DE602006004057 T DE 602006004057T DE 602006004057 T DE602006004057 T DE 602006004057T DE 602006004057 D1 DE602006004057 D1 DE 602006004057D1
Authority
DE
Germany
Prior art keywords
nem
manufacturing
method therefor
ace inhibitors
paharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006004057T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Evangelos Kotzagiorgis
Dimitrios Bikiaris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmathen SA
Original Assignee
Pharmathen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen SA filed Critical Pharmathen SA
Publication of DE602006004057D1 publication Critical patent/DE602006004057D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006004057T 2005-06-30 2006-06-29 Nem ace-hemmer und herstellungsverfahren dafür Active DE602006004057D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20050100332A GR1006875B (el) 2005-06-30 2005-06-30 Βελτιωμενες φαρμακευτικες συνθεσεις περιεχουσες αναστολεις του μετατρεπτικου ενζυμου αγγειοτενσινης και μεθοδοι παρασκευης αυτων.
PCT/GR2006/000033 WO2007003972A1 (en) 2005-06-30 2006-06-29 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof

Publications (1)

Publication Number Publication Date
DE602006004057D1 true DE602006004057D1 (de) 2009-01-15

Family

ID=38043070

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006004057T Active DE602006004057D1 (de) 2005-06-30 2006-06-29 Nem ace-hemmer und herstellungsverfahren dafür

Country Status (12)

Country Link
EP (1) EP1906931B1 (de)
AT (1) ATE415951T1 (de)
CA (1) CA2612742C (de)
CY (1) CY1108846T1 (de)
DE (1) DE602006004057D1 (de)
DK (1) DK1906931T3 (de)
ES (1) ES2318772T3 (de)
GR (1) GR1006875B (de)
HR (1) HRP20090102T3 (de)
PL (1) PL1906931T3 (de)
PT (1) PT1906931E (de)
WO (1) WO2007003972A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN114886866A (zh) * 2022-04-08 2022-08-12 苏州中化药品工业有限公司 一种格列齐特片(ⅱ)药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
JP2002535353A (ja) * 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物

Also Published As

Publication number Publication date
ATE415951T1 (de) 2008-12-15
CY1108846T1 (el) 2014-07-02
HRP20090102T3 (en) 2009-03-31
GR1006875B (el) 2010-07-12
CA2612742C (en) 2010-08-03
CA2612742A1 (en) 2007-01-11
DK1906931T3 (da) 2009-03-09
PT1906931E (pt) 2009-02-12
PL1906931T3 (pl) 2009-05-29
WO2007003972A1 (en) 2007-01-11
EP1906931A1 (de) 2008-04-09
ES2318772T3 (es) 2009-05-01
GR20050100332A (el) 2007-01-19
EP1906931B1 (de) 2008-12-03

Similar Documents

Publication Publication Date Title
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MX2010000856A (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
WO2008062476A3 (en) Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
TW200734334A (en) Treatment of substance abuse
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
WO2007044325A3 (en) Apoe4 domain interaction inhibitors and methods of use thereof
GR20050100466A (el) Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουναναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
EA201000613A1 (ru) Тризамещенные пиперидины
DE602006004057D1 (de) Nem ace-hemmer und herstellungsverfahren dafür
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
EA201000611A1 (ru) 4,4-дизамещенные пиперидины
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
WO2005082862A3 (en) Benzimidazolyl derivatives as kinase inhibitors
EA200801003A1 (ru) Фармацевтически приемлемые соли и гидраты ризедроновой кислоты
EA201000889A1 (ru) Тризамещенные пиперидины в качестве ингибиторов ренина
MX2007002384A (es) Nuevos derivados de cromen-2-ona y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
DK2041181T3 (da) Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition